Affiliation:
1. St. Petersburg State University of Veterinary Medicine
Abstract
In veterinary pharmacology, radiopharmaceuticals play a key role in the diagnosis and treatment of various diseases. These are special preparations containing radioactive isotopes, which provide high sensitivity and accuracy of visualization of internal organs and tissues as part of radionuclide diagnostics. In this regard, the production and use of radiopharmaceuticals requires strict adherence to certain requirements that ensure the safety and effectiveness of their use. Regular monitoring and safety assessment of the use of radiopharmaceuticals in veterinary medicine are mandatory measures to maintain a high level of professional animal care and protect the environment. The article discusses the main regulatory documents regulating the production and use of radiopharmaceuticals. In general, requirements for the production and use of radiopharmaceuticals are aimed at ensuring the safety of animals, personnel and the environment, as well as guaranteeing the high quality and effectiveness of the drugs used. Only strict compliance with all requirements will allow the medical community to fully exploit the potential of radiopharmaceuticals for the diagnosis and treatment of various diseases.
Publisher
Saint-Petersburg State University of Veterinary Medicine
Reference10 articles.
1. Patent No. 2781847 C1 Russian Federation, IPC A61B 6/03. Method for modeling the kinetics of osteotropic radiopharmaceuticals in the body of laboratory animals: No. 2021112919: application. 05/04/2021: publ. 10/18/2022 / A. V. Matveev, V. M. Petriev, V. K. Tishchenko, A. D. Kaprin; applicant Federal State Budgetary Educational Institution of Higher Education "Omsk State University named after F.M. Dostoevsky", Federal State Budgetary Institution "National Medical Research Center of Radiology" of the Ministry of Health of the Russian Federation.
2. Kosenko, V.V. Regulation of the circulation of radiopharmaceuticals / V.V. Kosenko, A.A. Trapkova, S.N. Kalmykov // Bulletin of the Scientific Center for Expertise of Medical Products. Regulatory research and examination of medicines. – 2022. – T. 12, No. 4. – P. 379-388. – DOI 10.30895/1991-2919-2022-12-4-379-388.
3. Shatik, S. V. Features of the regulatory status of radiopharmaceutical drugs manufactured in medical organizations / S. V. Shatik, D. N. Maistrenko, A. A. Stanzhevsky // Bulletin of the Scientific Center for Expertise of Medicinal Products. Regulatory research and examination of medicines. – 2022. – T. 12, No. 4. – P. 389-394. – DOI 10.30895/1991-2919-2022-12-4-389-394.
4. Lunev, A. S. Study of the pharmacokinetics of radiopharmaceuticals / A. S. Lunev, K. A. Luneva, O. E. Klementyeva // Bulletin of the Scientific Center for Expertise of Medical Products. Regulatory research and examination of medicines. – 2022. – T. 12, No. 4. – P. 395-403. – DOI 10.30895/1991-2919-2022-12-4-395-403.
5. Aspects of the problem of conducting clinical trials of modern targeted radiopharmaceuticals / E. Z. Rabinovich, A. Yu. Savchenko, V. Yu. Sukhov, V. V. Perelygin // Pharmacy Formulas. – 2022. – T. 4, No. 3. – P. 27-42. – DOI 10.17816/phf239422.